| ADR Ontology |
| ADR Term |
Hypersensitivity |
| ADR ID |
BADD_A02145 |
| ADR Hierarchy |
|
| Description |
Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. [MeSH] |
| MedDRA Code |
10020751 |
| MeSH ID |
D006967; D006967; D006967
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Acute allergic reaction | Allergic reaction | Allergic reaction NOS | Allergy | Allergy aggravated | Allergy NOS | Allergy, unspecified, not elsewhere classified | Hypersensitivity | Hypersensitivity NOS | Hypersensitivity reaction | Hypersensitivity reaction (NOS) | Hypersensitivity symptom | HYSN | Reaction allergic (NOS) | Reaction hypersensitivity (NOS) | Red neck syndrome | Upper respiratory tract hypersensitivity reaction, site unspecified | Allergic reaction (NOS) | Environmental allergy | Systemic allergic reaction | Hypersensitivities | Allergies | Allergic Reaction | Allergic Reactions | Reaction, Allergic | Reactions, Allergic |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| ATP-dependent bile acid permease | P32386 | Not Available | | ATP-dependent translocase ABCB1 | P08183 | T25258 | | Epoxide hydrolase 1 | P07099 | Not Available | | HLA class I histocompatibility antigen, B alpha chain | P01889 | Not Available | | Lanosterol 14-alpha demethylase | Q8K0C4 | Not Available | | N-alpha-acetyltransferase 20 | P61599 | Not Available |
|
| Drugs Leading to the ADR |
|
|
